Security Snapshot

ICU MEDICAL INC/DE - Common Stock (ICUI) Institutional Ownership

CUSIP: 44930G107

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

274

Shares (Excl. Options)

25,003,260

Price

$129.15

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-654,750
Value change
-$92,846,361
Number of holders
274
Security identity Names, identifiers, and filing context for this profile. 1 source field
Underlying class
Common Stock
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
24,707,266
SEC-reported price per share
$123.23
Insider filing price
$123.23
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • ICUI - ICU MEDICAL INC/DE - Common Stock is tracked under CUSIP 44930G107.
  • 274 institutions reported positions in Q1 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 291 to 274 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $3,660,353,422 to $3,224,658,486.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 274 institutions filings for Q1 2026.

Open SEC evidence

Security key

44930G107

Latest holder period

Q1 2026

13F holders

274

13D/G owners

4

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
ICUI
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 10% 0% $326,429,794 +$272,229 2,470,146 +0.08% JANUS HENDERSON GROUP PLC 30 Jun 2025
VANGUARD PORTFOLIO MANAGEMENT LLC 5.8% $188,012,050 1,455,765 Vanguard Portfolio Management 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.2% $167,695,980 1,298,459 Vanguard Capital Management 31 Mar 2026
FULLER & THALER ASSET MANAGEMENT, INC. 4.9% $157,632,605 1,220,539 Fuller & Thaler Asset Management, Inc. 31 Mar 2026

As of 31 Mar 2026, 274 institutional investors reported holding 25,003,260 shares of ICU MEDICAL INC/DE - Common Stock (ICUI). This represents 101% of the company’s total 24,707,266 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
79%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 15% 3,608,322 +0.56% 0.01% $466,014,786
JANUS HENDERSON GROUP PLC 11% 2,676,012 +3.9% 0.17% $345,607,263
VANGUARD PORTFOLIO MANAGEMENT LLC 5.8% 1,437,676 0% 0.01% $185,675,855
FULLER & THALER ASSET MANAGEMENT, INC. 4.9% 1,220,539 -3.6% 0.53% $157,632,605
VANGUARD CAPITAL MANAGEMENT LLC 4.5% 1,111,875 0% 0% $143,598,656
DIMENSIONAL FUND ADVISORS LP 4% 983,802 +6.8% 0.03% $127,052,704
STATE STREET CORP 3.9% 968,053 +2.7% 0% $125,024,045
SCHRODER INVESTMENT MANAGEMENT GROUP 2.8% 701,280 -8.4% 0.07% $87,926,486
River Road Asset Management, LLC 2.6% 646,430 -0.68% 0.95% $83,486,434
GEODE CAPITAL MANAGEMENT, LLC 2.5% 611,219 +3% 0% $78,953,719
AMERIPRISE FINANCIAL INC 2.5% 605,728 -8.4% 0.02% $78,230,031
MORGAN STANLEY 2.1% 526,842 +1.6% 0% $68,041,734
JPMORGAN CHASE & CO 1.9% 467,817 -12% 0% $58,654,917
NEUBERGER BERMAN GROUP LLC 1.8% 446,419 -21% 0.04% $57,655,014
Thrivent Financial for Lutherans 1.8% 433,499 +43% 0.11% $55,986,000
CITADEL ADVISORS LLC 1.3% 333,336 +58% 0.03% $43,050,344
BANK OF AMERICA CORP /DE/ 1.3% 331,739 +11% 0% $42,844,092
SILVERCREST ASSET MANAGEMENT GROUP LLC 1.3% 323,676 -15% 0.3% $41,803,144
GOLDMAN SACHS GROUP INC 1.3% 322,691 +13% 0.01% $41,675,478
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.3% 322,479 +4.2% 0.01% $41,648,163
FMR LLC 1.3% 312,923 -14% 0% $40,414,002
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 1.2% 294,319 +7.7% 0.07% $38,011,000
NORTHERN TRUST CORP 1.2% 293,699 -13% 0.01% $37,931,227
FEDERATED HERMES, INC. 1% 257,498 +4.2% 0.05% $33,255,866
Defilade Capital Management, L.P. 1% 254,291 -25% 5% $32,841,683

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 25,003,260 $3,224,658,486 -$92,846,361 $129.15 274
2025 Q4 25,641,931 $3,660,353,422 -$111,554,319 $142.67 291
2025 Q3 25,796,286 $3,091,441,219 +$77,553,211 $119.96 268
2025 Q2 25,082,538 $3,314,262,195 +$97,749,003 $132.15 273
2025 Q1 24,312,384 $3,381,985,980 +$22,039,356 $138.86 281
2024 Q4 24,213,401 $3,756,909,626 -$58,516,049 $155.17 285
2024 Q3 24,553,720 $4,467,331,041 +$76,905,236 $182.22 287
2024 Q2 23,790,393 $2,825,088,620 +$149,203,804 $118.75 256
2024 Q1 22,617,632 $2,427,031,471 +$116,351,455 $107.32 251
2023 Q4 21,600,686 $2,154,454,730 -$89,807,764 $99.74 241
2023 Q3 22,298,221 $2,653,725,397 -$35,106,953 $119.01 215
2023 Q2 22,249,048 $3,964,270,637 -$74,461,498 $178.19 227
2023 Q1 22,697,462 $3,743,979,121 +$70,541,615 $164.96 231
2022 Q4 22,295,759 $3,511,926,675 +$39,756,872 $157.48 241
2022 Q3 22,630,155 $3,408,280,475 -$240,293,324 $150.60 231
2022 Q2 21,624,606 $3,556,543,462 +$100,918,106 $164.39 246
2022 Q1 20,908,251 $4,657,377,472 +$150,898,618 $222.64 282
2021 Q4 20,185,157 $4,789,939,188 +$34,827,837 $237.34 288
2021 Q3 19,964,154 $4,660,018,823 -$53,955,352 $233.38 272
2021 Q2 20,303,486 $4,177,920,660 +$50,461,509 $205.80 266
2021 Q1 20,080,347 $4,125,473,068 +$114,043,017 $205.44 277
2020 Q4 19,530,259 $4,188,765,735 +$40,730,429 $214.49 273
2020 Q3 19,335,530 $3,533,762,551 -$33,121,822 $182.76 273
2020 Q2 19,504,752 $3,594,237,202 +$747,251 $184.31 285
2020 Q1 19,503,919 $3,933,938,959 -$44,075,766 $201.77 264
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .